{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:39:04Z","timestamp":1792089544452,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ajogmf.2020.100179","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T03:05:15Z","timestamp":1593745515000},"page":"100179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Buprenorphine-naloxone use in pregnancy: a\u00a0systematic review and metaanalysis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-8582","authenticated-orcid":false,"given":"Heather M.","family":"Link","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendree","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kaltenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Seligman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2020.100179_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajogmf.2020.100179_bib7","first-page":"358","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ajogmf.2020.100179_bib9","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1542\/peds.2013-3524","article-title":"Neonatal abstinence syndrome","volume":"134","author":"Kocherlakota","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajogmf.2020.100179_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08897077.2012.752779","article-title":"Treating opioid use disorders during pregnancy: historical, current, and future directions","volume":"34","author":"Jones","year":"2013","journal-title":"Subst Abus"},{"key":"10.1016\/j.ajogmf.2020.100179_bib12","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2020.100179_bib13","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100179_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajogmf.2020.100179_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.ajogmf.2020.100179_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1360-0443.2000.95223910.x","article-title":"Treatment of opioid-dependent pregnant women with buprenorphine","volume":"95","author":"Fischer","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.ajogmf.2020.100179_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130000637","article-title":"Effects of buprenorphine\/naloxone in opioid-dependent humans","volume":"154","author":"Stoller","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ajogmf.2020.100179_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1521-0391.2012.12005.x","article-title":"Buprenorphine\u00a0+ naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data","volume":"22","author":"Debelak","year":"2013","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajogmf.2020.100179_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011774","article-title":"Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population","volume":"6","author":"Jumah","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajogmf.2020.100179_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0000000000000640","article-title":"Buprenorphine and naloxone compared with methadone treatment in pregnancy","volume":"125","author":"Wiegand","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/2050312114530282","article-title":"Neonatal outcomes following in utero exposure to buprenorphine\/naloxone or methadone","volume":"2","author":"Gawronski","year":"2014","journal-title":"SAGE Open Med"},{"key":"10.1016\/j.ajogmf.2020.100179_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ajad.12687","article-title":"Treating women with opioid use disorder during pregnancy in Appalachia: initial neonatal outcomes following buprenorphine\u00a0+ naloxone exposure","volume":"27","author":"Nguyen","year":"2018","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajogmf.2020.100179_bib23","first-page":"185","article-title":"Buprenorphine and naloxone versus buprenorphine for opioid use disorder in pregnancy: a cohort study","volume":"14","author":"Mullins","year":"2020","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ajogmf.2020.100179_bib24","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/add.14192","article-title":"Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway","volume":"113","author":"Nechansk\u00e1","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.ajogmf.2020.100179_bib25","series-title":"Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants","year":"2018"},{"key":"10.1016\/j.ajogmf.2020.100179_bib26","series-title":"Guidelines for the identification and management of substance use and substance use disorders in pregnancy","year":"2015"},{"key":"10.1016\/j.ajogmf.2020.100179_bib27","series-title":"ACROBAT-NRSI: a Cochrane risk of bias assessment tool for non-randomized studies of interventions","author":"Sterne","year":"2016"},{"key":"10.1016\/j.ajogmf.2020.100179_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib29","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane handbook for systematic reviews of interventions. 2019. Available at: www.training.cochrane.org\/handbook. Accessed December 4, 2019.","DOI":"10.1002\/9781119536604"},{"key":"10.1016\/j.ajogmf.2020.100179_bib30","first-page":"61","article-title":"A\u00a0comparison of buprenorphine\u00a0+ naloxone to buprenorphine and methadone in the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes","volume":"7","author":"Lund","year":"2013","journal-title":"Subst Abuse"},{"key":"10.1016\/j.ajogmf.2020.100179_bib31","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeri\u00e1","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9378(75)90613-4","article-title":"Fetal stress from methadone withdrawal","volume":"122","author":"Zuspan","year":"1975","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1055\/s-0039-1688908","article-title":"Fetal outcomes with detoxification from opioid drugs during pregnancy: a systematic review","volume":"37","author":"Towers","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0038-1670680","article-title":"Opioid detoxification in pregnancy: systematic review and meta-analysis of perinatal outcomes","volume":"36","author":"Wang","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajogmf.2020.100179_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/bja\/58.1.45","article-title":"Placental transfer of naloxone","volume":"58","author":"Hibbard","year":"1986","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ajogmf.2020.100179_bib36","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1055\/s-0036-1593993","article-title":"Naloxone and metabolites quantification in cord blood of prenatally exposed newborns and correlations with maternal concentrations","volume":"6","author":"Wiegand","year":"2016","journal-title":"AJP Rep"},{"key":"10.1016\/j.ajogmf.2020.100179_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/tera.1420310208","article-title":"The interference of naloxone hydrochloride in the teratogenic activity of opiates","volume":"31","author":"Jurand","year":"1985","journal-title":"Teratology"},{"key":"10.1016\/j.ajogmf.2020.100179_bib40","author":"Hinde"},{"key":"10.1016\/j.ajogmf.2020.100179_bib41","first-page":"e194","article-title":"Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence: retrospective cohort study of 30 patients","volume":"62","author":"Dooley","year":"2016","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.ajogmf.2020.100179_bib42","first-page":"315","article-title":"A\u00a0review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ajogmf.2020.100179_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1016\/j.ajogmf.2020.100179_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J\u00a0Subst Abuse Treat"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:45:52Z","timestamp":1762904752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933320301233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2589933320301233"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100179","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine-naloxone use in pregnancy: a\u00a0systematic review and metaanalysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100179"}}